SCHEMBL130050

SCHEMBL130050

CC(C)N(c1cc[c]cc1)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1355916 0.80
SCHEMBL20438385 0.80 ALDH1A1 (0.39)
SCHEMBL2184765 0.77
SCHEMBL8415485 0.77
SCHEMBL12304286 0.72 ALDH1A1 (0.35)
SCHEMBL141145 0.72 ALDH1A1 (0.42)
SCHEMBL20438389 0.72 SMN1; SMN2 (0.37)
SCHEMBL129169 0.72
SCHEMBL5842489 0.72 ALDH1A1 (0.42)
SCHEMBL5842275 0.72 IGLV6-57 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3400231-A1 AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING MICROBIAL INFECTIONS Technion Research & Development Foundation Limited (IL) 2018-11-14 EP claimed
EP-3344641-A1 AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS Eloxx Pharmaceuticals Ltd. (IL) 2018-07-11 EP claimed
WO-2017118967-A1 AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING MICROBIAL INFECTIONS TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2017-07-13 WO claimed
WO-2017037719-A1 AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS ELOXX PHARMACEUTICALS LTD. (IL) 2017-03-09 WO claimed
US-20230181612-A1 AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS ELOXX PHARMACEUTICALS LTD. (IL) 2023-06-15 US disclosed
US-11613551-B2 Aminoglycoside derivatives and uses thereof in treating genetic disorders ELOXX PHARMACEUTICALS LTD. (IL) 2023-03-28 US disclosed
CN-114957357-A Aminoglycoside derivatives and their use in the treatment of genetic disorders ELOXX制药有限公司 2022-08-30 CN disclosed
US-20210300958-A1 AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS ELOXX PHARMACEUTICALS LTD. (IL) 2021-09-30 US disclosed
US-10899785-B2 Aminoglycoside derivatives and uses thereof in treating genetic disorders ELOXX PHARMACEUTICALS LTD. (IL) 2021-01-26 US disclosed
EP-3634973-A1 AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS Eloxx Pharmaceuticals Ltd. (IL) 2020-04-15 EP disclosed
US-20190016746-A1 AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS ELOXX PHARMACEUTICALS LTD. (IL) 2019-01-17 US disclosed
US-20190016745-A1 AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING MICROBIAL INFECTIONS TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2019-01-17 US disclosed
EP-0275381-B1 DYE TRANSFER PROCESS BASF Aktiengesellschaft (DE) 1992-03-04 EP disclosed
EP-0275381-A2 Dye transfer process BASF Aktiengesellschaft (DE) 1988-07-27 EP disclosed
US-4760049-A Dye transfer BASF AKTIENGESELLSCHAFT (DE) 1988-07-26 US disclosed
US-4652648-A STABILIZERS FOR HEAT, OXIDATION AND LIGHT CIBA-GEIGY CORPORATION (US) 1987-03-24 US disclosed
US-4579682-A HEAT, OXYGEN, AND LIGHT PROTECTION FOR POLYMERS CIBA-GEIGY CORPORATION (US) 1986-04-01 US disclosed
EP-0042359-B1 PHOSPHONOUS-ACID MONOESTER MONOAMIDE AND ORGANIC POLYMERS STABILIZED THEREWITH CIBA-GEIGY AG (CH) 1984-10-31 EP disclosed
US-4434109-A STABILIZERS AGAINST HEAT, OXYGEN AND LIGHT CIBA-GEIGY CORPORATION (US) 1984-02-28 US disclosed
EP-0042359-A1 Phosphonous-acid monoester monoamide and organic polymers stabilized therewith CIBA-GEIGY AG (CH) 1981-12-23 EP disclosed